Stay updated on Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial
Sign up to get notified when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.

Latest updates to the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedPublications section now notes that items are automatically filled from PubMed, and the revision tag has been updated to v3.3.2; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check21 days agoChange DetectedRemoved the government funding/status notice from the page. The core study information, including the title, conditions, eligibility criteria, and study plan, remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check36 days agoChange DetectedNo substantive changes to the study details are visible between the two screenshots; the content appears unchanged.SummaryDifference0.2%

- Check64 days agoChange DetectedUpdated core content with an operating-status notice and a new version (v3.2.0); removed a previous term and older version marker (v3.1.0).SummaryDifference1%

- Check71 days agoChange DetectedExpanded immunology and biomarker terminology and updated cancer nomenclature and page version (from v3.0.2 to v3.1.0).SummaryDifference0.5%

- Check85 days agoChange DetectedThe page has advanced to Revision: v3.0.2 with September 2025 updates, replacing the older v3.0.1 entries and removing earlier timestamps; a minor UI element ('Back to Top') was removed.SummaryDifference0.2%

Stay in the know with updates to Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cabozantinib and Immunotherapy in Genitourinary Tumors Clinical Trial page.